Recombinant human PDCD5 protein enhances chemosensitivity of breast cancer in vitro and in vivo

Biochemistry and Cell Biology

Volumn 91, Issue 6, 2013, Pages 526-531

  Wang, Lanlan ^a   Wang, Changjun ^a   Su, Bingnan ^a   Song, Quansheng ^a   Zhang, Yingmei ^a   Luo, Yang ^a   Li, Qi ^a   Tan, Weifeng ^a   Ma, Dalong ^a   Wang, Lu ^b  

^a PEKING UNIVERSITY HEALTH SCIENCE CENTER   (China)

^b PEKING UNIVERSITY   (China)

Author keywords

breast cancer; chemosensitivity; chemotherapy; paclitaxel; PDCD5

Indexed keywords

ANIMALS; ANTINEOPLASTIC AGENTS, PHYTOGENIC; APOPTOSIS REGULATORY PROTEINS; BREAST NEOPLASMS; CELL LINE, TUMOR; CELL PROLIFERATION; DRUG RESISTANCE, NEOPLASM; DRUG SYNERGISM; DRUG THERAPY, COMBINATION; FEMALE; HUMANS; INJECTIONS, INTRAPERITONEAL; MICE; MICE, NUDE; NEOPLASM PROTEINS; PACLITAXEL; RECOMBINANT PROTEINS; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 84894241753     PISSN: 08298211     EISSN: 12086002     Source Type: Journal    
DOI: 10.1139/bcb-2013-0052     Document Type: Article

References (33)

1. Chen D.J. Huerta S. 2009. Smac mimetics as new cancer therapeutics. Anticancer Drugs, 20: 646-658. 10.1097/CAD.0b013e32832ced78. 19550293.
2. Chen Y. Sun R. Han W. Zhang Y. Song Q. Di C. Ma D. 2001. Nuclear translocation of PDCD5 (TFAR19): an early signal for apoptosis? FEBS Lett. 509: 191-196. 10.1016/S0014-5793(01)03062-9. 11741587.
3. Chen C. Zhou H. Xu L. Xu D. Wang Y. Zhang Y. Liu X. Liu Z. Ma D. Ma Q. Chen Y. 2010. Recombinant human PDCD5 sensitizes chondrosarcomas to cisplatin chemotherapy in vitro and in vivo. Apoptosis, 15: 805-813. 10.1007/s10495-010- 0489-5. 20349137.
4. Choi J.S. Jo B.W. Kim Y.C. 2004. Enhanced paclitaxel bioavailability after oral administration of paclitaxel or prodrug to rats pretreated with quercetin. Eur. J. Pharm. Biopharm. 57: 313-318. 10.1016/j.ejpb.2003.11.002. 15018990.
5. Goel A. Aggarwal B.B. 2010. Curcumin, the golden spice from Indian saffron, is a chemosensitizer and radiosensitizer for tumors and chemoprotector and radioprotector for normal organs. Nutr. Cancer, 62: 919-930. 10.1080/01635581.2010.509835. 20924967.
6. Gupta S.C. Kannappan R. Reuter S. Kim J.H. Aggarwal B.B. 2011. Chemosensitization of tumors by resveratrol. Ann. N.Y. Acad. Sci. 1215: 150-160. 10.1111/j.1749-6632.2010.05852.x. 21261654.
7. Han X.R. Sun Y. Bai X.Z. 2012. The anti-tumor role and mechanism of integrated and truncated PDCD5 proteins in osteosarcoma cells. Cell. Signal. 24: 1713-1721. 10.1016/j.cellsig.2012.04.011. 22560879.
8. Hedenfalk I. Duggan D. Chen Y. Radmacher M. Bittner M. Simon R. Meltzer P. Gusterson B. Esteller M. Kallioniemi O.P. Wilfond B. Borg A. Trent J. Raffeld M. Yakhini Z. Ben-Dor A. Dougherty E. Kononen J. Bubendorf L. Fehrle W. Pittaluga S. Gruvberger S. Loman N. Johannsson O. Olsson H. Sauter G. 2001. Gene-expression profiles in hereditary breast cancer. N. Engl. J. Med. 344: 539-548. 10.1056/NEJM200102223440801. 11207349.
9. Huizing M.T. Sewberath Misser V.H. Pieters R.C. ten Bokkel Huinink W.W. Veenhof C.H.N. Vermorken J.B. et al. 1995. Taxanes: a new class of antitumor agents. Cancer Invest. 13: 381-404. 10.3109/07357909509031919. 7627725.
10. Innocenti F. Danesi R. Di Paolo A. Agen C. Nardini D. Bocci G. et al. 1995. Plasma and tissue disposition of paclitaxel (taxol) after intraperitoneal administration in mice. Drug Metab. Dispos. 23: 713-717. 7587959.
11. Król M. Pawłowski K.M. Majchrzak K. Szyszko K. Motyl T. 2010. Why chemotherapy can fail? Pol. J. Vet. Sci. 13: 399-406. 20731201.
12. Li H. Wang Q. Gao F. Zhu F. Wang X. Zhou C. Liu C. Chen Y. Ma C. Sun W. Zhang L. 2008. Reduced expression of PDCD5 is associated with high-grade astrocytic gliomas. Oncol. Rep. 20: 573-579. 10.3892/or-00000044. 18695908.
13. Li H. Zhang X. Song X. Zhu F. Wang Q. Guo C. Liu C. Shi Y. Ma C. Wang X. Zhang L. 2012. PDCD5 promotes cisplatin-induced apoptosis of glioma cells via activating mitochondrial apoptotic pathway. Cancer Biol. Ther. 13 (9): 822-830. 10.4161/cbt.20565. 22688731.
14. Liu H. Wang Y. Zhang Y. Song Q. Di C. Chen G. Tang J. Ma D. 1999. TFAR19, a novel apoptosis-related gene cloned from human leukemia cell line TF-1, could enhance apoptosis of some tumor cells induced by growth factor withdrawal. Biochem. Biophys. Res. Commun. 254: 203-210. 10.1006/bbrc.1998.9893. 9920759.
15. Mauri D. Polyzos N.P. Salanti G. Pavlidis N. Ioannidis J.P. 2008. Multiple-treatments meta-analysis of chemotherapy and targeted therapies in advanced breast cancer. J. Natl. Cancer Inst. 100: 1780-1791. 10.1093/jnci/djn414. 19066278.
16. McCloskey D.E. Kaufmann S.H. Prestigiacomo L.J. Davidson N.E. 1996. Paclitaxel induces programmed cell death in MDA-MB-468 human breast cancer cells. Clin. Cancer Res. 2: 847-854. 9816240.
17. Milas L. Raju U. Liao Z. Ajani J. 2005. Targeting molecular determinants of tumor chemo-radioresistance. Semin. Oncol. 32: S78-S81. 10.1053/j.seminoncol. 2005.04.028. 16399438.
18. Moulder S. 2010. Intrinsic resistance to chemotherapy in breast cancer. Womens Health (Lond. Engl.), 6: 6821-6830. 10.2217/whe.10.60. 21118040.
19. Rebecca S. Deepa N. Ahmedin J. 2012. Cancer Statistics, 2012. CA Cancer J. Clin. 62: 10-29. 10.3322/caac.20138. 22237781.
20. Rivera E. Gomez H. 2010. Chemotherapy resistance in metastatic breast cancer: the evolving role of ixabepilone. Breast Cancer Res. 2: s2. 10.1186/bcr2573. 21050423.
21. Ruan G. Qin Y. Chen S. Li J.L. Ma X. Chang Y. Wang Y. Fu J.Y. Liu Y.R. 2006. Abnormal expression of the programmed cell death 5 gene in acute and chronic myeloid leukemia. Leuk. Res. 30: 1159-1165. 10.1016/j.leukres.2005.12. 028. 16507320.
22. Ruan G.R. Zhao H.S. Chang Y. Li J.L. Qin Y.Z. Liu Y.R. Chen S.S. Huang X.J. 2008. Adenovirus-mediated PDCD5 gene transfer sensitizes K562 cells to apoptosis induced by idarubicin in vitro and in vivo. Apoptosis, 13: 641-648. 10.1007/s10495-008-0206-9. 18401719.
23. Saxena R. Dwivedi A. 2012. ErbB family receptor inhibitors as therapeutic agents in breast cancer: current status and future clinical perspective. Med. Res. Rev. 1: 166-215. 10.1002/med.20209. 22183797.
24. Shi L. Song Q. Zhang Y. Lou Y. Wang Y. Tian L. Zheng Y. Ma D. Ke X. Wang Y. 2010. Potent antitumor activities of recombinant human PDCD5 protein in combination with chemotherapy drugs in K562 cells. Biochem. Biophys. Res. Commun. 396: 224-230. 10.1016/j.bbrc.2010.04.068. 20398626.
25. Siegel R. Naishadham D. Jemal A. 2012. Cancer Statistics, 2012. CA Cancer J. Clin. 62: 10-29. 10.3322/caac.20138. 22237781.
26. Wang Y. Li D. Fan H. Tian L. Zhong Y. Zhang Y. Yuan L. Jin C. Yin C. Ma D. 2006. Cellular uptake of exogenous human PDCD5 protein. J. Biol. Chem. 281: 24803-24817. 10.1074/jbc.M600183200. 16754680.
27. Wang N. Lu H.S. Guan Z.P. Sun T.Z. Chen Y.Y. Ruan G.R. Chen Z.K. Jiang J. Bai C.J. 2007. Involvement of PDCD5 in the regulation of apoptosis in fibroblast-like synoviocytes of rheumatoid arthritis. Apoptosis, 12: 1433-1441. 10.1007/s10495-007-0070-z. 17468978.
28. Wang Y. Shi L. Song Q. Zhang Y. Lou Y. Zheng Y. Ma D. Wang Y. 2009. Recombinant human PDCD5 protein enhances chemosensitivities of hematologic malignancies. Chin. Sci. Bull. 54: 3981-3989. 10.1007/s11434-009-0635-z.
29. Xu X. Huang J. Xu Z. Qian B. Zhu Z. Yan Q. Cai T. Zhang X. Xiao H.S. Qu J. Liu F. Huang Q.H. Cheng Z.H. Li N.G. Du J.J. Hu W. Shen K.T. Lu G. Fu G. Zhong M. Xu S.H. Gu W.Y. Huang W. Zhao X.T. Hu G.X. Gu J.R. Chen Z. Han Z.G. 2001. Insight into hepatocellular carcinogenesis at transcriptome level by comparing gene expression profiles of hepatocellular carcinoma with those of corresponding noncancerous liver. Proc. Natl. Acad. Sci. U.S.A. 98: 15089-15094. 10.1073/pnas.241522398. 11752456.
30. Xu L. Chen Y. Song Q. Xu D. Wang Y. Ma D. 2009. PDCD5 interacts with Tip60 and functions as a cooperator in acetyltransferase activity and DNA damage-induced apoptosis. Neoplasia, 11: 345-354. 19308289.
31. Xu H.Y. Chen Z.W. Pan Y.M. Fan L. Guan J. Lu Y.Y. 2012. Transfection of PDCD5 Effect on the Biological Behavior of Tumor Cells and Sensitized Gastric Cancer Cells to Cisplatin-Induced Apoptosis. Dig. Dis. Sci. 57: 1847-1856. 10.1007/s10620-012-2090-y. 22359193.
32. Yang Y. Zhao M. Li W. Chen Y. Kang B. Lu Y. 2006. Expression of programmed cell death 5 gene involves in regulation of apoptosis in gastric tumor cells. Apoptosis, 11: 993-1001. 10.1007/s10495-006-6714-6. 16547588.
33. Zhang X. Wang X. Song X. Wei Z. Zhou C. Zhu F. Wang Q. Ma C. Zhang L. 2011. Clinical and prognostic significance of lost or decreased PDCD5 expression in human epithelial ovarian carcinomas. Oncol. Rep. 25: 353-358. 10.3892/or.2010.1103. 21165576.